Pfizer Inc. (NYSE:PFE) is scheduled to release its financial results for the second quarter, before the opening bell on Tuesday. Analysts expect the New York-based company to report quarterly earnings at 46 cents per share, down from 67 cents per share in the year-ago period. Pfizer expects to post revenue of $13.02 billion, compared to $12.73 billion a year earlier, according to data from Benzinga Pro. On July 25, Pfizer announced that the European Commission approved a conditional marketing authorization for DURVEQTIX, a gene therapy for severe and moderately severe hemophilia B in adults whom meet certain criteria. Pfizer shares fell 0.2% to close at $30.72 on Monday. Benzinga readers can access the latest analyst ...